Table 3.
TAT (nM) | PAI-1 (nM) | Fg (mg/mL) | |
---|---|---|---|
S1 | 119 ± 29 | 2.20 ± 0.42 | 3.50 ± 1.04 |
S2 | 139 ± 26 | 0.29 ± 0.08 | 2.27 ± 0.18 |
S3 | 99 ± 16 | 0.11 ± 0.03 | 2.39 ± 0.16 |
S4 | 197 ± 28 | 0.61 ± 0.21 | 2.13 ± 0.09 |
S5 | 158 ± 24 | 0.25 ± 0.03 | 2.92 ± 0.82 |
TAT (nM) | PAI-1 (nM) | Fg (mg/mL) | |
---|---|---|---|
S1 | 119 ± 29 | 2.20 ± 0.42 | 3.50 ± 1.04 |
S2 | 139 ± 26 | 0.29 ± 0.08 | 2.27 ± 0.18 |
S3 | 99 ± 16 | 0.11 ± 0.03 | 2.39 ± 0.16 |
S4 | 197 ± 28 | 0.61 ± 0.21 | 2.13 ± 0.09 |
S5 | 158 ± 24 | 0.25 ± 0.03 | 2.92 ± 0.82 |